Question 1

What is Recordati?

Accepted Answer

Recordati is a Company.

Question 2

How often does Recordati appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Recordati first tracked by Ergen?

Accepted Answer

First tracked on Jun 25, 2026.

Question 4

When was Recordati last mentioned in news?

Accepted Answer

Last active on Jun 26, 2026.

Question 5

What is Recordati's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Recordati in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Recordati?

Accepted Answer

Ionis, Recordati License Zilganersen (Jun 25, 2026, 6 articles).

Question 8

How did the "Ionis, Recordati License Zilganersen" event impact Recordati?

Accepted Answer

Recordati obtained exclusive rights to develop and commercialize zilganersen outside the U.S., expanding its rare diseases portfolio with a potentially transformative therapy for Alexander disease.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.